Shoji, H., Takahashi, N., Hara, H., Ando, T., Makiyama, A., Matsuyama, J., Kawabata, R., Imamura, H., Minashi, K., Yamada, T., Kito, Y., Osumi, H., Furuta, M., Nagashima, K., Matsumoto, T., Hirata, K., Kawakami, H., Yamazaki, K., Hironaka, S., Muro, K. (2026). Randomized phase II trial of trifluridine/tipiracil (FTD/TPI) plus ramucirumab (RAM) versus FTD/TPI for previously treated patients with advanced gastric or gastroesophageal junction adenocarcinoma: Final analysis of RETRIEVE study (WJOG 15822G).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.4038